Pfizer (PFE) Prepaid Assets (2009 - 2026)

Pfizer has disclosed Prepaid Assets across 16 years of filings, most recently posting $2.9 billion for Q1 2026.

• In Q1 2026, Prepaid Assets fell 1.32% year-over-year to $2.9 billion; the TTM figure through Mar 2026 stood at $2.9 billion (down 1.32% YoY), while the FY2025 annual figure was $2.8 billion, down 33.98% from the prior year.
• Prepaid Assets climbed to $2.9 billion in Q1 2026, from $2.8 billion in the prior quarter.
• Over the last five years, Prepaid Assets for PFE reached as high as $6.1 billion in Q4 2022 and fell as low as $2.4 billion in Q3 2025.
• The 5-year median for Prepaid Assets is $4.3 billion (2024), against an average of $4.2 billion.
• Annual changes were most pronounced in 2022 — Prepaid Assets soared 62.24% — and 2025, when it sank 38.83%.
• A 5-year view of Prepaid Assets shows it stood at $5.0 billion in 2022, then slipped by 2.11% to $4.9 billion in 2023, then fell by 13.4% to $4.3 billion in 2024, then sank by 33.98% to $2.8 billion in 2025, then climbed by 3.56% to $2.9 billion in 2026.
• According to Business Quant data, Prepaid Assets over the past three periods registered $2.9 billion, $2.8 billion, and $2.4 billion for Q1 2026, Q4 2025, and Q3 2025 respectively.